Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US74276L1052
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG009KD84H4
PRCT
Procept Biorobotics Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Medical Devices · THEMEFOLIO: $RBTX
NAME
Procept Biorobotics Corp
ISIN
US74276L1052
TICKER
PRCT
MIC
XNAS
REUTERS
PRCT.OQ
BLOOMBERG
PRCT US
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

Did you buy PRCT common stock between February 28, 2024 and February 25, 2026?Affected PRCT Investor SummaryWho: PROCEPT BioRobotics Corporation (NASDAQ: PRCT)What: Securities fraud class action lawsuit filedClass Period: February 28, 2024 through February 25, 2026Deadline to Seek Lead Plaintiff Status: September 22, 2026Key Lawsuit Allegations: M...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - August 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline.SO WHAT...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

LOS ANGELES, Aug. 4, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against PROCEPT BioRobotics Corporation. IF YOU SUFFERED A LOSS ON YOUR PROCEPT BIOROBOTICS CORPORAT...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

BENSALEM, Pa., Aug. 4, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against PROCEPT BioRobotics Corporation. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PROCEPT BIOROBOTICS CORPORATION (PRCT), CONTACT THE LAW OFFICES OF...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended June 30, 2026....
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - August 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ: PRCT) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period").CLIC...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT). Shareholders who purchased shares of PRCT during the class period listed are encouraged to contact the firm regarding possible lead...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

A securities fraud class action lawsuit has been filed on behalf of Procept investors after its stock plummeted 18% because Procept allegedly artificially inflated its financial performance via an extensive discount program that incentivized customers to place bulk orders.NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you w...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 03.08.2026       PROCEPT BioRobotics
US74276L1052

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 3, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit a...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.08.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ: PRCT) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period").CLIC...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.08.2026       PROCEPT BioRobotics
US74276L1052

San Diego, California--(Newsfile Corp. - August 3, 2026) - Robbins LLP reminds investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period").Investors who suffered significant losses du...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.08.2026       PROCEPT BioRobotics
US74276L1052

LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shar...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Sun, 02.08.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - August 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Sat, 01.08.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK and NEW ORLEANS, July 31, 2026 /PRNewswire/ -- - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRoboti...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Sat, 01.08.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - July 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Fri, 31.07.2026       PROCEPT BioRobotics
US74276L1052

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against PROCEPT BioRobotics Corporation (PROCEPT) (NASDAQ: PRCT) on behalf of those who purchased or acquired PROCEPT common stock between February 28, 2024 and...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Fri, 31.07.2026       PROCEPT BioRobotics
US74276L1052

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 31, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit ag...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Fri, 31.07.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ: PRCT) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period").CLICK...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 31.07.2026       PROCEPT BioRobotics
US74276L1052

LOS ANGELES, July 31, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sha...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       PROCEPT BioRobotics
US74276L1052

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDAQ: PRCT) securities between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT investors have until Septe...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       PROCEPT BioRobotics
US74276L1052

Institutional investors and fiduciaries may need to assess PRCT losses tied to allegations that Procept's undisclosed handpiece discount program inflated recurring revenue metrics and pulled forward demand.NEW YORK, July 30, 2026 /PRNewswire/ -- SueWallSt notifies institutional investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a sec...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       PROCEPT BioRobotics
US74276L1052

Levi & Korsinsky, LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed on behalf of shareholders who purchased securities between February 28, 2024 and February 25, 2026. Find out if you may qualify to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsk...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       PROCEPT BioRobotics
US74276L1052

Law Offices of Howard G. Smith reminds investors of the upcoming September 22, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) securities between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”).IF...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.07.2026       PROCEPT BioRobotics
US74276L1052

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, both dates inclusive (the “Class Period”), have until September 22, 2026 to seek appointment as lead plaintiff of the Procept class action lawsuit. Captioned...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.07.2026       PROCEPT BioRobotics
US74276L1052

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 29, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit ag...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.07.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - July 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has alr...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.07.2026       PROCEPT BioRobotics
US74276L1052

Time-Sensitive: Allegations focus on Procept's assurances about the handpiece-to-procedure differential and explanations that attributed revenue volatility to transient saline shortages rather than alleged inventory overstocking.NEW YORK, July 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in PROCEPT BIOROBOTICS CORPORATION (N...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.07.2026       PROCEPT BioRobotics
US74276L1052

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ:PRCT) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws.If you invested in...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.07.2026       PROCEPT BioRobotics
US74276L1052

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 20...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.07.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, July 27, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.07.2026       PROCEPT BioRobotics
US74276L1052

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (“the Class Period”). If you suffered a loss on your Procept investments,...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.07.2026       PROCEPT BioRobotics
US74276L1052

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NasdaqGM: PRC...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.07.2026       PROCEPT BioRobotics
US74276L1052

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDAQ: PRCT) securities between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT investors have until September 22, 2026 to file a lea...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 27.07.2026       PROCEPT BioRobotics
US74276L1052

Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT is a medical technology company.For more information, submit a form, email attorne...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 27.07.2026       PROCEPT BioRobotics
US74276L1052

SAN DIEGO, July 27, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period")....
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 27.07.2026       PROCEPT BioRobotics
US74276L1052

The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of PRCT during...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 27.07.2026       PROCEPT BioRobotics
US74276L1052

SAN DIEGO, July 27, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), have until September 22, 2026 to seek appointment as lead plaintiff of the Procept cl...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Mon, 27.07.2026       PROCEPT BioRobotics
US74276L1052

LOS ANGELES, July 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sha...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Sun, 26.07.2026       PROCEPT BioRobotics
US74276L1052

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commi...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Sat, 25.07.2026       PROCEPT BioRobotics
US74276L1052

Robbins LLP informs investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period").Investors who suffered significant losses during the Class Period may be eligible to participate in the...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.07.2026       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the second quarter of 2026 after market close on Tuesday, August 4...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.04.2026       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2026....
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       PROCEPT BioRobotics
US74276L1052

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROCEPT BIOROBOTICS...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       PROCEPT BioRobotics
US74276L1052

Law Offices of Howard G. Smith continues its investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PROCEPT BIOROBOTICS CORPORATION (PRCT), CONTACT THE LAW OFFICES OF HOWARD...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       PROCEPT BioRobotics
US74276L1052

The Law Offices of Frank R. Cruz continues its investigation of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROCEPT BIOROBOTICS CORPORATION (PRCT), CLICK HERE TO INQUIRE ABOUT PO...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2026 after market close on Wednesday, April...
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink
Thu, 26.03.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
PROCEPT BioRobotics
Technical Analysis Termsheets Terminal
Permalink